Cleavage site recognition by SARS-CoV-2 main protease as new antiviral drug target
The main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cleaves the proteins produced by the virus at various […]
» Read moreHome »
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), cases […] Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), cases […]
Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19
Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19